Obiekt
Tytuł: Development of a novel recombinant TRAIL-IFNγ fusion protein for targeted anti-cancer therapy
Abstrakt:
TRAIL/Apo2L has been catching attention of many researchers focused on the development of cancer therapies since its discovery. The interest in the molecule results from the fact that almost from the very beginning it has been identified as a molecule capable of inducing apoptosis in cancer cells while maintaining safety against healthy cells. Thus, the discovery of TRAIL initiated the exploration of the concept of using Death Receptors in targeted therapies. So far, however, no company has managed to implement the novel drug based on that. The concept of "enriching" TRAIL analogues with domains exhibiting an additional, different than apoptosis, mechanism of action is currently being explored. One of the proposed solutions is to obtain fusions of recombinant Apo2L/TRAIL and human interferon domains. The added value of such structures should be: stimulation of immune system cells to fight cancer, targeted delivery of interferon, extension of t1/2 of recombinant TRAIL and sensitization of cancer cells to TRAIL-induced apoptosis. The recombinant TRAIL-IFN fusion described in this study, shows a significant advantage over the recombinant human variant of TRAIL in most of the research models used – cytotoxic activity in vitro, mechanisms of cell death, cell cycle analysis, cell morphology, in vivo antitumor efficacy. However there may appear following problems in the further develo ; pment of the drug: the stability of the molecule itself (and its formulation) and the selection of the optimal therapeutic dose, to maintain the desired activity and safety profile for both components of the recombinant molecule.
Miejsce wydania:
Stopień studiów:
Dyscyplina:
Instytucja nadająca tytuł:
Rada Dyscypliny Nauki farmaceutyczne
Promotor:
Data wydania:
Identyfikator:
Sygnatura:
Język:
Prawa dostępu:
Kolekcje, do których przypisany jest obiekt:
Data ostatniej modyfikacji:
15 kwi 2024
Data dodania obiektu:
15 kwi 2024
Liczba wyświetleń treści obiektu:
12
Liczba wyświetleń treści obiektu w formacie PDF
0
Wszystkie dostępne wersje tego obiektu:
http://dl.cm-uj.krakow.pl:8080/publication/5083
Wyświetl opis w formacie RDF:
Wyświetl opis w formacie OAI-PMH:
| Nazwa wydania | Data |
|---|---|
| ZB-134099 | 15 kwi 2024 |
Obiekty
Podobne
Żerek, Bartłomiej
Rózga, Piotr
Kruczak, Katarzyna.
Kruczak, Katarzyna
Gibek, Katarzyna
Abdel-Kader, Rania.
The effect of farnesyltransferase inhibitor on the proliferation and the apoptosis of melanoma cells
Ostrowska, Barbara
